These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33070902)

  • 1. How SARS-Cov-2 can involve the central nervous system. A systematic analysis of literature of the department of human neurosciences of Sapienza University, Italy.
    Armocida D; Palmieri M; Frati A; Santoro A; Pesce A
    J Clin Neurosci; 2020 Sep; 79():231-236. PubMed ID: 33070902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations and comorbidity associated with COVID-19: an overview.
    Kumar M; Thakur AK
    Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
    Li YC; Bai WZ; Hashikawa T
    J Med Virol; 2020 Jun; 92(6):552-555. PubMed ID: 32104915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    Yashavantha Rao HC; Jayabaskaran C
    J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
    Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
    J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological complications of coronavirus and COVID-19.
    Carod-Artal FJ
    Rev Neurol; 2020 May; 70(9):311-322. PubMed ID: 32329044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights.
    Mandal N; De N; Jana P; Sannigrahi A; Chattopadhyay K
    ACS Chem Neurosci; 2020 Sep; 11(18):2789-2792. PubMed ID: 32880441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Dysfunction in Coronavirus Disease-19 (COVID-19).
    Parry AH; Wani AH; Yaseen M
    Acad Radiol; 2020 Sep; 27(9):1329-1330. PubMed ID: 32546339
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
    Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
    Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.
    Barrantes FJ
    ACS Chem Neurosci; 2020 Sep; 11(18):2793-2803. PubMed ID: 32845609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations of SARS-CoV-2 - a systematic review.
    Słyk S; Domitrz I
    Neurol Neurochir Pol; 2020; 54(5):378-383. PubMed ID: 32667047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Jarrahi A; Ahluwalia M; Khodadadi H; da Silva Lopes Salles E; Kolhe R; Hess DC; Vale F; Kumar M; Baban B; Vaibhav K; Dhandapani KM
    J Neuroinflammation; 2020 Sep; 17(1):286. PubMed ID: 32998763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reissuing the sigma receptors for SARS-CoV-2.
    Yesilkaya UH; Balcioglu YH; Sahin S
    J Clin Neurosci; 2020 Oct; 80():72-73. PubMed ID: 33099370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know.
    Paybast S; Emami A; Koosha M; Baghalha F
    Acta Neurol Taiwan; 2020 Mar; 29(1)():24-31. PubMed ID: 32285431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19.
    Puccioni-Sohler M; Poton AR; Franklin M; Silva SJD; Brindeiro R; Tanuri A
    Rev Soc Bras Med Trop; 2020; 53():e20200477. PubMed ID: 33027418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae.
    Pallanti S; Grassi E; Makris N; Gasic GP; Hollander E
    J Psychiatr Res; 2020 Nov; 130():215-217. PubMed ID: 32836010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.